The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: rituximab     Quarter: 2016Q3

Total Records: 1,104     Number of Pages: 56

DRUGNAME PT EventCount
RITUXIMAB Bone marrow oedema 1
Rituximab Bowen's disease 1
Rituximab Brachial plexopathy 1
RITUXIMAB Bradycardia 1
Rituximab Brain injury 1
Rituximab Breast disorder 1
Rituximab Bronchopneumopathy 1
Rituximab Budd-Chiari syndrome 1
RITUXIMAB Cachexia 1
RITUXIMAB Campylobacter infection 1
RITUXIMAB Cardiac failure congestive 1
Rituximab Cardiac hypertrophy 1
RITUXIMAB Carditis 1
RITUXIMAB Catheter site infection 1
RITUXIMAB Central nervous system lupus 1
RITUXIMAB Cerebral haemorrhage 1
rituximab Cerebral toxoplasmosis 1
Rituximab Cervix carcinoma 1
Rituximab Cervix carcinoma stage I 1
Rituximab Cholangitis 1

Total Records: 1,104     Number of Pages: 56